FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotan, R.

The FASEB Journal, Vol 10, 1031-1039, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Retinoids in cancer chemoprevention

R Lotan
Department of Tumor Biology, University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA.

Naturally occurring and synthetic vitamin A metabolites and analogs (retinoids) inhibit tumor development in a variety of cellular, animal, and patient studies. They suppress transformation of cells in vitro and inhibit carcinogenesis in various organs in animal models. In a mouse skin carcinogenesis model, topical retinoids exhibit suppressive effects on tumor promotion, but have no effect on tumor initiation. In other models, retinoids administered in the diet suppress tumor development even in an adjuvant setting after excision of the first tumor. Retinoids suppress carcinogenesis in individuals with premalignant lesions and a high risk to develop cancer of the aerodigestive tract. Likewise, retinoids prevent the development of second primary cancers in head/neck and lung cancer patients who had been treated for the first primary. The mechanisms underlying the anticarcinogenic activity of retinoids appear to be associated with the ability of retinoids to modulate the growth, differentiation, and apoptosis of normal, premalignant, and malignant cells in vitro and in vivo. Most of these effects are mediated by nuclear retinoid receptors, but other mechanisms may also be involved. These studies indicate that retinoids are potentially useful agent for cancer chemoprevention.


This article has been cited by other articles:


Home page
 Arch Otolaryngol Head Neck SurgHome page
K. Chen, R. Sawhney, M. Khan, M. S. Benninger, Z. Hou, S. Sethi, J. K. Stephen, and M. J. Worsham
Methylation of Multiple Genes as Diagnostic and Therapeutic Markers in Primary Head and Neck Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, November 1, 2007; 133(11): 1131 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. R. Howe
Rexinoids and Breast Cancer Prevention
Clin. Cancer Res., October 15, 2007; 13(20): 5983 - 5987.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Ohnuma-Ishikawa, T. Morio, T. Yamada, Y. Sugawara, M. Ono, M. Nagasawa, A. Yasuda, C. Morimoto, K. Ohnuma, N. H. Dang, et al.
Knockdown of XAB2 Enhances All-Trans Retinoic Acid-Induced Cellular Differentiation in All-Trans Retinoic Acid-Sensitive and -Resistant Cancer Cells
Cancer Res., February 1, 2007; 67(3): 1019 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. J. Donato, J. H. Suh, and N. Noy
Suppression of Mammary Carcinoma Cell Growth by Retinoic Acid: the Cell Cycle Control Gene Btg2 Is a Direct Target for Retinoic Acid Receptor Signaling
Cancer Res., January 15, 2007; 67(2): 609 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
W. O. Ward, D. A. Delker, S. D. Hester, S.-F. Thai, D. C. Wolf, J. W. Allen, and S. Nesnow
Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil
Toxicol Pathol, December 1, 2006; 34(7): 863 - 878.
[Abstract] [PDF]

Home page
 Pharmacol. Rev.Home page
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LX. Retinoic Acid Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Osanai, M. Murata, N. Nishikiori, H. Chiba, T. Kojima, and N. Sawada
Epigenetic Silencing of Occludin Promotes Tumorigenic and Metastatic Properties of Cancer Cells via Modulations of Unique Sets of Apoptosis-Associated Genes.
Cancer Res., September 15, 2006; 66(18): 9125 - 9133.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. Castillo, D. Giacomini, M. Paez-Pereda, J. Stalla, M. Labeur, M. Theodoropoulou, F. Holsboer, A. B. Grossman, G. K. Stalla, and E. Arzt
Retinoic Acid as a Novel Medical Therapy for Cushing's Disease in Dogs
Endocrinology, September 1, 2006; 147(9): 4438 - 4444.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Xu, S. Cheepala, E. McCauley, K. Coombes, L. Xiao, S. M. Fischer, and J. L. Clifford
Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor-Independent Tumor Suppression
Clin. Cancer Res., February 1, 2006; 12(3): 969 - 979.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Unterholzner, M. J. Willhauck, N. Cengic, M. Schutz, B. Goke, J. C. Morris, and C. Spitzweg
Dexamethasone Stimulation of Retinoic Acid-Induced Sodium Iodide Symporter Expression and Cytotoxicity of 131-I in Breast Cancer Cells
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 69 - 78.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Giacomini, M. Paez-Pereda, M. Theodoropoulou, M. Labeur, D. Refojo, J. Gerez, A. Chervin, S. Berner, M. Losa, M. Buchfelder, et al.
Bone Morphogenetic Protein-4 Inhibits Corticotroph Tumor Cells: Involvement in the Retinoic Acid Inhibitory Action
Endocrinology, January 1, 2006; 147(1): 247 - 256.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. B. Thomas and J. L. Abbruzzese
Opportunities for Targeted Therapies in Hepatocellular Carcinoma
J. Clin. Oncol., November 1, 2005; 23(31): 8093 - 8108.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. M. de Almeida Vasconcelos Fonseca, C. E. A. Chagas, R. P. Mazzantini, R. Heidor, T. P. Ong, and F. S. Moreno
All-trans and 9-cis retinoic acids, retinol and {beta}-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage
Carcinogenesis, November 1, 2005; 26(11): 1940 - 1946.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. J. Donato and N. Noy
Suppression of Mammary Carcinoma Growth by Retinoic Acid: Proapoptotic Genes Are Targets for Retinoic Acid Receptor and Cellular Retinoic Acid-Binding Protein II Signaling
Cancer Res., September 15, 2005; 65(18): 8193 - 8199.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Osanai and M. Petkovich
Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death
Mol. Pharmacol., May 1, 2005; 67(5): 1808 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Elisei, A. Vivaldi, L. Agate, R. Ciampi, E. Molinaro, P. Piampiani, C. Romei, P. Faviana, F. Basolo, P. Miccoli, et al.
All-Trans-Retinoic Acid Treatment Inhibits the Growth of Retinoic Acid Receptor {beta} Messenger Ribonucleic Acid Expressing Thyroid Cancer Cell Lines but Does Not Reinduce the Expression of Thyroid-Specific Genes
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2403 - 2411.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Jeronimo, R. Henrique, M. O. Hoque, F. R. Ribeiro, J. Oliveira, D. Fonseca, M. R. Teixeira, C. Lopes, and D. Sidransky
Quantitative RAR{beta}2 Hypermethylation: A Promising Prostate Cancer Marker
Clin. Cancer Res., June 15, 2004; 10(12): 4010 - 4014.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Y. Park, I. J. Cho, and S. G. Kim
Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer
Cancer Res., May 15, 2004; 64(10): 3701 - 3713.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Tanaka, B. L. Dancheck, L. C. Trifiletti, R. E. Birnkrant, B. J. Taylor, S. H. Garfield, U. Thorgeirsson, and L. M. De Luca
Altered Localization of Retinoid X Receptor {alpha} Coincides with Loss of Retinoid Responsiveness in Human Breast Cancer MDA-MB-231 Cells
Mol. Cell. Biol., May 1, 2004; 24(9): 3972 - 3982.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. E. Mao, V. E. Reuter, C. Cordon-Cardo, G. Dalbagni, H. I. Scher, J. B. deKernion, Z.-F. Zhang, and J. Rao
Decreased Retinoid X Receptor-{alpha} Protein Expression in Basal Cells Occurs in the Early Stage of Human Prostate Cancer Development
Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 383 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P. Prakash, C. Liu, K.-Q. Hu, N. I. Krinsky, R. M. Russell, and X.-D. Wang
{beta}-Carotene and {beta}-Apo-14'-Carotenoic Acid Prevent the Reduction of Retinoic Acid Receptor {beta} in Benzo[a]pyrene-Treated Normal Human Bronchial Epithelial Cells
J. Nutr., March 1, 2004; 134(3): 667 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. M. Youssef, D. Lotan, J.-P. Issa, K. Wakasa, Y.-H. Fan, L. Mao, K. Hassan, L. Feng, J. J. Lee, S. M. Lippman, et al.
Hypermethylation of the Retinoic Acid Receptor-{beta}2 Gene in Head and Neck Carcinogenesis
Clin. Cancer Res., March 1, 2004; 10(5): 1733 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Shimizu, M. Suzui, A. Deguchi, J. T. E. Lim, and I. B. Weinstein
Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells
Clin. Cancer Res., February 1, 2004; 10(3): 1130 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. M. Russell
The Enigma of {beta}-Carotene in Carcinogenesis: What Can Be Learned from Animal Studies
J. Nutr., January 1, 2004; 134(1): 262S - 268.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Shah, A. Hecht, R. Pestell, and S. W. Byers
Trans-repression of {beta}-Catenin Activity by Nuclear Receptors
J. Biol. Chem., November 28, 2003; 278(48): 48137 - 48145.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Shaw, M. Elholm, and N. Noy
Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor {beta}/{delta}
J. Biol. Chem., October 24, 2003; 278(43): 41589 - 41592.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Gumireddy, L. N. Sutton, P. C. Phillips, and C. D. Reddy
All-trans-Retinoic Acid-induced Apoptosis in Human Medulloblastoma: Activation of Caspase-3/Poly(ADP-ribose) Polymerase 1 Pathway
Clin. Cancer Res., September 15, 2003; 9(11): 4052 - 4059.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y.-Y. Fan, T. E. Spencer, N. Wang, M. P. Moyer, and R. S. Chapkin
Chemopreventive n-3 fatty acids activate RXR{alpha} in colonocytes
Carcinogenesis, September 1, 2003; 24(9): 1541 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Manor, E. N. Shmidt, A. Budhu, A. Flesken-Nikitin, M. Zgola, R. Page, A. Yu. Nikitin, and N. Noy
Mammary Carcinoma Suppression by Cellular Retinoic Acid Binding Protein-II
Cancer Res., August 1, 2003; 63(15): 4426 - 4433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K.-H. Chun, D. M. Benbrook, K. D. Berlin, W. K. Hong, and R. Lotan
The Synthetic Heteroarotinoid SHetA2 Induces Apoptosis in Squamous Carcinoma Cells through a Receptor-independent and Mitochondria-dependent Pathway
Cancer Res., July 1, 2003; 63(13): 3826 - 3832.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Zhuang, T. N. Faria, P. Chambon, and L. J. Gudas
Identification and Characterization of Retinoic Acid Receptor {beta}2 Target Genes in F9 Teratocarcinoma Cells
Mol. Cancer Res., June 1, 2003; 1(8): 619 - 630.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
N. Matt, N. B. Ghyselinck, O. Wendling, P. Chambon, and M. Mark
Retinoic acid-induced developmental defects are mediated by RAR{beta}/RXR heterodimers in the pharyngeal endoderm
Development, May 15, 2003; 130(10): 2083 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al.
Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells
J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. C. Ross
Retinoid Production and Catabolism: Role of Diet in Regulating Retinol Esterification and Retinoic Acid Oxidation
J. Nutr., January 1, 2003; 133(1): 291S - 296.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. T. Christov, R. C. Moon, D. D. Lantvit, C. W. Boone, V. E. Steele, R. A. Lubet, G. J. Kelloff, and J. M. Pezzuto
9-cis-Retinoic Acid but Not 4-(Hydroxyphenyl)retinamide Inhibits Prostate Intraepithelial Neoplasia in Noble Rats
Cancer Res., September 15, 2002; 62(18): 5178 - 5182.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Wolf
The effect of {beta}-carotene on lung and skin carcinogenesis
Carcinogenesis, August 1, 2002; 23(8): 1263 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Guo, B. S. Knudsen, D. M. Peehl, A. Ruiz, D. Bok, R. R. Rando, J. S. Rhim, D. M. Nanus, and L. J. Gudas
Retinol Metabolism and Lecithin:Retinol Acyltransferase Levels Are Reduced in Cultured Human Prostate Cancer Cells and Tissue Specimens
Cancer Res., March 1, 2002; 62(6): 1654 - 1661.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Cerignoli, X. Guo, B. Cardinali, C. Rinaldi, J. Casaletto, L. Frati, I. Screpanti, L. J. Gudas, A. Gulino, C. J. Thiele, et al.
retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines
Cancer Res., February 1, 2002; 62(4): 1196 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
R. Montesano and P. Soulie
Retinoids induce lumen morphogenesis in mammary epithelial cells
J. Cell Sci., January 12, 2002; 115(23): 4419 - 4431.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. M. Schildkraut, B. Calingaert, P. A. Marchbanks, P. G. Moorman, and G. C. Rodriguez
Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk
J Natl Cancer Inst, January 2, 2002; 94(1): 32 - 38.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. C. Rodriguez, N. P. Nagarsheth, K. L. Lee, R. C. Bentley, D. K. Walmer, M. Cline, R. S. Whitaker, P. Isner, A. Berchuck, R. K. Dodge, et al.
Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-{beta}
J Natl Cancer Inst, January 2, 2002; 94(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Vivat-Hannah, D. You, C. Rizzo, J.-P. Daris, P. Lapointe, F. C. Zusi, A. Marinier, M. V. Lorenzi, and M. M. Gottardis
Synergistic Cytotoxicity Exhibited by Combination Treatment of Selective Retinoid Ligands with Taxol (Paclitaxel)
Cancer Res., December 1, 2001; 61(24): 8703 - 8711.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Hatoum, M. E. El-Sabban, J. Khoury, S. H. Yuspa, and N. Darwiche
Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis
Carcinogenesis, December 1, 2001; 22(12): 1955 - 1963.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Okuno, T. Sano, R. Matsushima-Nishiwaki, S. Adachi, K. Akita, Y. Okano, S. Kojima, and H. Moriwaki
Apoptosis Induction by Acyclic Retinoid: a Molecular Basis of 'Clonal Deletion' Therapy for Hepatocellular Carcinoma
Jpn. J. Clin. Oncol., August 1, 2001; 31(8): 359 - 362.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Chung, C. Liu, D. E. Smith, H. K. Seitz, R. M. Russell, and X.-D. Wang
Restoration of retinoic acid concentration supresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver
Carcinogenesis, August 1, 2001; 22(8): 1213 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. I. Song, M. N. Lango, J. D. Hwang, S. D. Drenning, Q. Zeng, W. W. Lamph, and J. R. Grandis
Abrogation of Transforming Growth Factor-{alpha}/Epidermal Growth Factor Receptor Autocrine Signaling by an RXR-selective Retinoid (LGD1069, Targretin) in Head and Neck Cancer Cell Lines
Cancer Res., August 1, 2001; 61(15): 5919 - 5925.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Gupta, R. Nines, K. A. Rodrigo, R. A. Aziz, P. S. Carlton, D. L. Gray, V. E. Steele, M. A. Morse, and G. D. Stoner
Effects of Dietary N-(4-Hydroxyphenyl)retinamide on N-Nitrosomethylbenzylamine Metabolism and Esophageal Tumorigenesis in the Fischer 344 Rat
J Natl Cancer Inst, July 4, 2001; 93(13): 990 - 998.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. R. Benoit, M. Flexor, F. Besancon, L. Altucci, A. Rossin, J. Hillion, Z. Balajthy, L. Legres, E. Segal-Bendirdjian, H. Gronemeyer, et al.
Autonomous Rexinoid Death Signaling Is Suppressed by Converging Signaling Pathways in Immature Leukemia Cells
Mol. Endocrinol., July 1, 2001; 15(7): 1154 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Demary, L. Wong, J. S. Liou, D. V. Faller, and R. A. Spanjaard
Redox Control of Retinoic Acid Receptor Activity: A Novel Mechanism for Retinoic Acid Resistance in Melanoma Cells
Endocrinology, June 1, 2001; 142(6): 2600 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Klaassen, R. H. Brakenhoff, S. J. Smeets, G. B. Snow, and B. J. M. Braakhuis
Enhanced Turnover of all-trans-Retinoic Acid and Increased Formation of Polar Metabolites in Head and Neck Squamous Cell Carcinoma Lines Compared with Normal Oral Keratinocytes
Clin. Cancer Res., April 1, 2001; 7(4): 1017 - 1025.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
H. Wan, W. K. Hong, and R. Lotan
Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) {beta} by Expression of Exogenous Retinoid Receptors Retinoid X Receptor {{alpha}}, RAR{{alpha}}, and RAR{{gamma}}
Cancer Res., January 1, 2001; 61(2): 556 - 564.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
C. Liu, X.-D. Wang, R. T. Bronson, D. E. Smith, N. I. Krinsky, and R. M. Russell
Effects of physiological versus pharmacological {beta}-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets
Carcinogenesis, December 1, 2000; 21(12): 2245 - 2253.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S.-Y. Sun, P. Yue, R. A. S. Chandraratna, Y. Tesfaigzi, W. K. Hong, and R. Lotan
Dual Mechanisms of Action of the Retinoid CD437: Nuclear Retinoic Acid Receptor-Mediated Suppression of Squamous Differentiation and Receptor-Independent Induction of Apoptosis in UMSCC22B Human Head and Neck Squamous Cell Carcinoma Cells
Mol. Pharmacol., September 1, 2000; 58(3): 508 - 514.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
L. A. Hansen, C. C. Sigman, F. Andreola, S. A. Ross, G. J. Kelloff, and L. M. De Luca
Retinoids in chemoprevention and differentiation therapy
Carcinogenesis, July 1, 2000; 21(7): 1271 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. M. Lippman and R. Lotan
Advances in the Development of Retinoids as Chemopreventive Agents
J. Nutr., February 1, 2000; 130(2): 479 - 479.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. Luo, E. Guerin, M.-G. Ludwig, I. Stoll, P. Basset, and P. Anglard
Transcriptional Induction of Stromelysin-3 in Mesodermal Cells Is Mediated by an Upstream CCAAT/Enhancer-binding Protein Element Associated with a DNase I-hypersensitive Site
J. Biol. Chem., December 24, 1999; 274(52): 37177 - 37185.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Marchetti, N. Zamzami, B. Joseph, S. Schraen-Maschke, C. Mereau-Richard, P. Costantini, D. Metivier, S. A. Susin, G. Kroemer, and P. Formstecher
The Novel Retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene Carboxylic Acid Can Trigger Apoptosis through a Mitochondrial Pathway Independent of the Nucleus
Cancer Res., December 1, 1999; 59(24): 6257 - 6266.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-R. Chen, G. Zhou, and T.-H. Tan
c-Jun N-Terminal Kinase Mediates Apoptotic Signaling Induced by N-(4-Hydroxyphenyl)retinamide
Mol. Pharmacol., December 1, 1999; 56(6): 1271 - 1279.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
X.-C. Xu, J. S. Lee, J. J. Lee, R. C. Morice, X. Liu, S. M. Lippman, W. K. Hong, and R. Lotan
Nuclear Retinoid Acid Receptor Beta in Bronchial Epithelium of Smokers Before and During Chemoprevention
J Natl Cancer Inst, August 4, 1999; 91(15): 1317 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Chen, J. Buck, and F. Derguini
Anhydroretinol Induces Oxidative Stress and Cell Death
Cancer Res., August 1, 1999; 59(16): 3985 - 3990.
[Abstract] [Full Text] [PDF]